[Is there an indication for neoadjuvant or adjuvant systemic therapy in renal cell cancer?]. [electronic resource]
Producer: 20080114Description: 1371-2, 1374, 1376-8 p. digitalISSN:- 0340-2592
- Antineoplastic Agents -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Cancer Vaccines -- administration & dosage
- Carcinoma, Renal Cell -- drug therapy
- Chemotherapy, Adjuvant
- Clinical Trials, Phase III as Topic
- Combined Modality Therapy
- Disease-Free Survival
- Fluorouracil -- administration & dosage
- Humans
- Interferon-alpha -- administration & dosage
- Interleukin-2 -- administration & dosage
- Kidney Neoplasms -- drug therapy
- Neoadjuvant Therapy
- Neoplasm Staging
- Nephrectomy
- Survival Rate
No physical items for this record
Publication Type: English Abstract; Journal Article
There are no comments on this title.
Log in to your account to post a comment.